Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative, waking EEG research on depression.

V E Pollock1, L S Schneider

  • 1Department of Psychiatry, University of Southern California School of Medicine, Los Angeles.

Biological Psychiatry
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia.

The journal of prevention of Alzheimer's disease·2023
Same author

Viewpoint: When It Comes to Lecanemab (and Donanemab), How Might We Think about 'Reasonable and Necessary'?

The journal of prevention of Alzheimer's disease·2023
Same author

Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial.

The journal of prevention of Alzheimer's disease·2022
Same author

Editorial: Aducanumab Trials EMERGE But Don't ENGAGE.

The journal of prevention of Alzheimer's disease·2022
Same author

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2022
Same author

Commentary: The EU/US Task Force's Future for Anti-Amyloid Trials: Faites Vos Jeux.

The journal of prevention of Alzheimer's disease·2020

Depressed patients show higher waking electroencephalogram (EEG) alpha and beta activity compared to controls. Methodological differences in studies, however, complicate comparisons of other EEG findings in depression research.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Quantitative Electroencephalography (qEEG)

Background:

  • Depression is a complex mood disorder with varied neurophysiological correlates.
  • Quantitative electroencephalography (EEG) offers objective measures of brain activity.
  • Previous research has explored EEG differences in depressed individuals, but findings are often inconsistent.

Purpose of the Study:

  • To review quantitative EEG findings in depressed patients over the last decade.
  • To identify consistencies and inconsistencies in EEG characteristics associated with depression.
  • To discuss methodological challenges impacting comparability and suggest future research directions.

Main Methods:

  • Systematic review of published research using quantitative indices for waking EEG in depressed patients.

Related Experiment Videos

  • Analysis of studies from the past 10 years.
  • Identification of common methodological issues across studies.

    • Main Results:

    • Unmedicated, actively depressed patients consistently show elevated EEG alpha and beta activity compared to control groups.
    • EEG delta and theta activity showed less consistent differences between depressed patients and controls.
    • Methodological variations (diagnostic heterogeneity, lack of controls, differing EEG techniques) limit direct comparison of findings.

    Conclusions:

    • Elevated waking EEG alpha and beta activity are potential biomarkers for depression.
    • Standardization of methodologies is crucial for future qEEG depression research.
    • Further research is needed to clarify the role of other EEG frequencies and to differentiate depression from other psychiatric disorders using qEEG.